Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibody Response After Vaccination”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01777308
What this trial is testing

Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' MenACWY-TT Vaccine Administered 6 Years Post-MenC Primary Vaccination in Healthy Subjects Who Were 12-18 Months at Primary Vaccination

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 156
Testing effectiveness (Phase 2)Study completedNCT00715910
What this trial is testing

The Long-term Antibody Persistence of GSK Biologicals' Meningococcal Vaccine GSK134612 in Healthy Adolescents/Adults

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 818
Testing effectiveness (Phase 2)Study completedNCT03719066
What this trial is testing

Extended Dose Intervals With Oral Cholera Vaccine in Cameroon

Who this might be right for
Adverse Reaction to Cholera VaccineCholera Vaccination Reaction
Johns Hopkins Bloomberg School of Public Health 181
Post-approval studies (Phase 4)Study completedNCT00503529
What this trial is testing

TBE Antibody Persistence and Booster Vaccination Study in Adults (Follow-up to Study 223)

Who this might be right for
Encephalitis, Tick-Borne
Pfizer 314
Post-approval studies (Phase 4)UnknownNCT00262015
What this trial is testing

Kinetic of Immune Memory Response After Re-Vaccination With Meningococcal Vaccine

Who this might be right for
Meningococcal Disease; Meningococcal Meningitis
Chiron Corporation 264
Not applicableUnknownNCT05145348
What this trial is testing

Prospective Monitoring of Antibody Response Following COVID-19 Vaccination in Patients With Down Syndrome.

Who this might be right for
Down SyndromeSARS-CoV-2 Vaccination
UMC Utrecht 640
Large-scale testing (Phase 3)Study completedNCT02360514
What this trial is testing

Study to Evalutate Long-term Immunity of Hantavax in High Risk Population of HFRS

Who this might be right for
Infection
Green Cross Corporation 226
Post-approval studies (Phase 4)Study completedNCT00984139
What this trial is testing

Persistence of Immunity Against Hepatitis B in 12-13 Year Old Adolescents After Infant Hepatitis B Vaccination

Who this might be right for
Hepatitis B
GlaxoSmithKline 306
Not applicableUnknownNCT00172328
What this trial is testing

Antibody Response and Immune Memory 15-18 Years After HBV Vaccination

Who this might be right for
Hepatitis BVaccine
National Taiwan University Hospital
Not applicableStudy completedNCT00161941
What this trial is testing

Follow-up Study on the Antibody Response to Hepatitis B, Acellular Pertussis Toxin and Inactivated Poliovirus Antigens 1 Month After the 4th Hexavac® Vaccination in Healthy Children, Who Participated in NeisVac-C Study 216

Who this might be right for
Meningococcal Meninigitis, Serogroup C
Pfizer 321
Early research (Phase 1)Study completedNCT00279734
What this trial is testing

Vaccination Study of Abatacept (BMS-188667) for Normal Healthy Volunteers

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 80
Testing effectiveness (Phase 2)Study completedNCT01239043
What this trial is testing

Antibody Persistence and Response to Re-vaccination With Either Menactra® or Menomune® 3 Years After Initial Vaccination

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Sanofi 139
Not applicableStudy completedNCT04841785
What this trial is testing

RECOVAC - Long Term Efficacy and Safety of COVID-19 (SARS-CoV-2) Vaccination in Kidney Disease Patients

Who this might be right for
Covid19SARS-CoV InfectionChronic Kidney Diseases
University Medical Center Groningen 4,868
Post-approval studies (Phase 4)Study completedNCT00310713
What this trial is testing

Persistence of Antibodies and Kinetics of B Cell Response in Healthy Children After Vaccination With MCC Vaccine

Who this might be right for
Prevention of Meningococcal Infection
Novartis Vaccines 33
Post-approval studies (Phase 4)Active Not RecruitingNCT03023631
What this trial is testing

Gardasil 9 Vaccine in Preventing HPV Infection in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplant RecipientHematopoietic and Lymphoid Cell Neoplasm
M.D. Anderson Cancer Center 48
Large-scale testing (Phase 3)Study completedNCT01139021
What this trial is testing

One Year Antibody Persistence After a Fourth Dose Boost or Two Catch-Up Doses of Novartis Meningococcal B Recombinant Vaccine Administered Starting From 12 Months of Age and Response to a Third Dose Boost or Two Catch-Up Doses Starting at 24 Months of Age

Who this might be right for
Meningococcal Disease
Novartis Vaccines 508
Not applicableStudy completedNCT04871945
What this trial is testing

Protective Antibody Level After COVID-19 Vaccination Among Patients Under Hemodialysis

Who this might be right for
Covid19Vaccine ReactionHemolysis+1 more
Hanyang University Seoul Hospital 31
Not applicableStudy completedNCT01066169
What this trial is testing

Vaccination Response in ImmunoCompromised Host. Immune Response After Vaccination Against Pandemic A/H1N1 Influenza

Who this might be right for
HIV
Leiden University Medical Center 104
Early research (Phase 1)UnknownNCT05338177
What this trial is testing

Pilot Trial on Immunosuppression Modulation to Increase SARS-CoV-2 Vaccine Response in Kidney Transplant Recipients

Who this might be right for
COVID-19
Medical University of Vienna 40
Testing effectiveness (Phase 2)Study completedNCT00886964
What this trial is testing

Hepatitis B Vaccination (HBV) in HIV Infected Children

Who this might be right for
HIV Infections
The HIV Netherlands Australia Thailand Research Collaboration 80
Next Page